ATE487485T1 - Verwendung von d-ribose zur behandlung von vorhofflimmern - Google Patents

Verwendung von d-ribose zur behandlung von vorhofflimmern

Info

Publication number
ATE487485T1
ATE487485T1 AT08713225T AT08713225T ATE487485T1 AT E487485 T1 ATE487485 T1 AT E487485T1 AT 08713225 T AT08713225 T AT 08713225T AT 08713225 T AT08713225 T AT 08713225T AT E487485 T1 ATE487485 T1 AT E487485T1
Authority
AT
Austria
Prior art keywords
atrial fibrillation
ribose
treat atrial
treat
doses
Prior art date
Application number
AT08713225T
Other languages
German (de)
English (en)
Inventor
James Herrick
Original Assignee
Bioenergy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioenergy Inc filed Critical Bioenergy Inc
Application granted granted Critical
Publication of ATE487485T1 publication Critical patent/ATE487485T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT08713225T 2007-01-23 2008-01-23 Verwendung von d-ribose zur behandlung von vorhofflimmern ATE487485T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88194007P 2007-01-23 2007-01-23
PCT/US2008/000845 WO2008091618A1 (en) 2007-01-23 2008-01-23 Use of d-ribose to treat cardiac arrhythmias

Publications (1)

Publication Number Publication Date
ATE487485T1 true ATE487485T1 (de) 2010-11-15

Family

ID=39264528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08713225T ATE487485T1 (de) 2007-01-23 2008-01-23 Verwendung von d-ribose zur behandlung von vorhofflimmern

Country Status (10)

Country Link
US (1) US8101581B2 (enExample)
EP (1) EP2120968B1 (enExample)
JP (1) JP5396387B2 (enExample)
CN (1) CN101588807B (enExample)
AT (1) ATE487485T1 (enExample)
BR (1) BRPI0806231A2 (enExample)
CA (1) CA2674717C (enExample)
DE (1) DE602008003411D1 (enExample)
ES (1) ES2352154T3 (enExample)
WO (1) WO2008091618A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
JP5396387B2 (ja) 2007-01-23 2014-01-22 バイオエナジー インコーポレイティド 心臓不整脈を治療するためのｄ−リボースの用途
CN106138071A (zh) * 2008-04-02 2016-11-23 生物能公司 核糖在对于急性心肌梗塞的第一反应中的用途
EP3411041A1 (en) 2016-02-01 2018-12-12 RiboCor, Inc. Use of ribose for treatment of subjects having congestive heart failure

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605644A (en) 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
US4719201A (en) 1985-02-07 1988-01-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia
US4824660A (en) 1985-06-06 1989-04-25 Paul S. Angello Method of determining the viability of tissue in an organism
DE4228215A1 (de) 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
RU2127548C1 (ru) 1996-06-26 1999-03-20 Алабовский Владимир Владимирович Способ коронарографии в эксперименте
DE19650754A1 (de) * 1996-12-06 1998-06-10 Wolfgang Dr Pliml Ribose und Schlaganfall
US6159942A (en) 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6218366B1 (en) 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US20020119933A1 (en) 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6534480B2 (en) 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
US6511964B2 (en) 1999-09-24 2003-01-28 Bioenergy, Inc. Method for treating acute mountain sickness
US6159943A (en) 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
US6339716B1 (en) 1999-09-24 2002-01-15 Bioenergy Inc. Method for determining viability of a myocardial segment
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
JP4927282B2 (ja) 1999-12-21 2012-05-09 バイオエナジー インコーポレイティド 血小板の保存のための組成物
CA2397707A1 (en) 2000-01-07 2001-07-19 Susan S. Percival Compositions for enhancing the immune response
US6525027B2 (en) 2000-01-20 2003-02-25 Bioenergy Inc. Use of ribose supplementation for increasing muscle mass and decreasing body fat in humans
US6420342B1 (en) 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
IT1317043B1 (it) * 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
US20030212006A1 (en) 2002-05-13 2003-11-13 Seifert John G. Method for reducing free radical formation in healthy individuals undergoing hypoxic exercise and medical conditions with increased oxygen free radicals
US8486859B2 (en) 2002-05-15 2013-07-16 Bioenergy, Inc. Use of ribose to enhance plant growth
US7687468B2 (en) 2003-05-14 2010-03-30 Viacell, LLC. Rejuvenation of stored blood
US8759315B2 (en) 2003-05-14 2014-06-24 Viacell, Llc Methods for rejuvenating
US20040229205A1 (en) 2003-05-16 2004-11-18 Ericson Daniel G. Compositions for the storage of platelets
US20090197818A1 (en) 2004-01-14 2009-08-06 St Cyr John A Use Of Ribose for Recovery From Anaesthesia
WO2005107768A2 (en) 2004-04-29 2005-11-17 Bioenergy, Inc. Method for improving ventilatory efficiency
US20100099630A1 (en) 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
PT1800675E (pt) * 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
US8835396B2 (en) 2006-12-15 2014-09-16 Bioenergy, Inc. Method and compositions for improving pulmonary hypertension
JP5396387B2 (ja) 2007-01-23 2014-01-22 バイオエナジー インコーポレイティド 心臓不整脈を治療するためのｄ−リボースの用途
US20090197819A1 (en) 2007-03-20 2009-08-06 Clarence Albert Johnson Compositions for improving and repairing skin
US20080312169A1 (en) 2007-03-20 2008-12-18 Clarence Albert Johnson Cosmetic use of D-ribose
US20090232750A1 (en) 2008-03-13 2009-09-17 St Cyr John A Compositions for indoor tanning
CN106138071A (zh) 2008-04-02 2016-11-23 生物能公司 核糖在对于急性心肌梗塞的第一反应中的用途
US20090286750A1 (en) 2008-05-16 2009-11-19 Kasubick Robert V Use of ribose in lessening the clinical symptoms of aberrant firing of neurons

Also Published As

Publication number Publication date
US20080176809A1 (en) 2008-07-24
EP2120968A1 (en) 2009-11-25
ES2352154T3 (es) 2011-02-16
US8101581B2 (en) 2012-01-24
CA2674717A1 (en) 2008-07-31
WO2008091618A8 (en) 2010-04-01
DE602008003411D1 (de) 2010-12-23
CA2674717C (en) 2015-10-13
BRPI0806231A2 (pt) 2011-09-06
JP2010526884A (ja) 2010-08-05
EP2120968B1 (en) 2010-11-10
JP5396387B2 (ja) 2014-01-22
WO2008091618A1 (en) 2008-07-31
CN101588807B (zh) 2012-07-04
CN101588807A (zh) 2009-11-25

Similar Documents

Publication Publication Date Title
CY1121135T1 (el) Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
ECSP10010310A (es) Nuevos compuestos y composiciones y métodos de uso
TW200637522A (en) Skin treatment articles and methods
EA201270803A1 (ru) Тиоацетатные соединения, композиции на их основе и способы их применения
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA201100794A1 (ru) Замещенные пиримидины, предназначенные для лечения заболеваний, таких как рак
EA201100564A1 (ru) Антипролиферативные соединения
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA202091999A3 (ru) Применение ингибиторов dpp iv
TW200714604A (en) Substituted heterocycles and the uses thereof
EA200970575A1 (ru) Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения
PA8637201A1 (es) Difenilimidazopirimidina e-imidazol aminas como inhibidores de la b-secretasa
WO2009026657A8 (en) Flavonoid ppar agonists
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
TN2011000482A1 (en) Organic compounds and their uses
CL2011000798A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
NO20084749L (no) Organiske forbindelser og deres anvendelser
CU20100032A7 (es) Depsipéptidos cíclicos
CY1116216T1 (el) Μεθοδος θεραπειας ασθενειας αποθηκευσης γλυκογονου
MX342947B (es) Tratamiento de diabetes tipo 2.
CL2011000806A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
PH12012502070A1 (en) Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders
EA201100254A1 (ru) Новые соединения
NO20092073L (no) Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav
DE602006019468D1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2120968

Country of ref document: EP